E. Schönbrunn

7.1k citations

96 papers · 5.4k indexed · h-index 42

Impact in

Molecular Biology top 2%
- Protein Degradation and Inhibitors
- Plant tissue culture and regeneration
- Protein Structure and Dynamics
- Ubiquitin and proteasome pathways
Pollution top 2%
- Pesticide and Herbicide Environmental Studies

Papers in

Hematology 19
- Multiple Myeloma Research and Treatments 18
Molecular Biology 81
- Protein Degradation and Inhibitors 25
- Ubiquitin and proteasome pathways 17
- Biochemical and Molecular Research 13

Co-authors: Susanne Eschenburg Eckhard Mandelkow�Alexander Marx Huijong Han Mathew P. Martin Nikolaus Amrhein T. Funke Wolfgang Kabsch
Journals: Journal of Medicinal Chemistry (15 papers)Journal of Biological Chemistry (9 papers)Biochemistry (9 papers)ACS Chemical Biology (8 papers)ChemMedChem (4 papers)
Partner nations: United States Germany Switzerland

In The Last Decade

E. Schönbrunn

95 papers receiving 5.3k citations

Peers

Countries citing papers authored by E. Schönbrunn

Since Specialization

Citations

This map shows the geographic impact of E. Schönbrunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Schönbrunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Schönbrunn more than expected).

Fields of papers citing papers by E. Schönbrunn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Schönbrunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Schönbrunn. The network helps show where E. Schönbrunn may publish in the future.

Co-authorship network

The 25 scholars most cited alongside E. Schönbrunn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E. Schönbrunn Line = papers co-authored together E. Schönbrunn links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Macrocyclic dihydropyridine analogs as pan-BET BD2-preferred inhibitors European Journal of Medicinal Chemistry ·J Vianden, T. Jake Liang, Jonathan Solberg, Hao Luo, Jorge Riganti, Rui Shi, William C. K. Pomerantz, Jon E. Hawkinson, E. Schönbrunn, Gunda I. Georg	2025	0
2	Discovery and design of molecular glue enhancers of CDK12–DDB1 interactions for targeted degradation of cyclin K RSC Chemical Biology ·M Maróth, Maximilian Schmitz, S. E. Akuskina, Solomon Tadesse, Кадырметов, Samuel N. Mitchell, Frank van der Wel, Vinayak Palve, 신수진, K. Anand, Sylvia M. Frydman, William Roush, E. Schönbrunn, Matthias Geyer, Derek R. Duckett, Andrii Monastyrskyi	2024	3
3	Strategies for developing retinoic acid receptor alpha-selective antagonists as novel agents for male contraception European Journal of Medicinal Chemistry ·Chris Mahood, Rebecca A. D. Cuellar, Zahra Rezaeiasl, Sanny S.W. Chung, K Jedlicka, Abdelkarim Daoudi, Mark Anthony Gonzales, 平賀健二, H.L.S. Wong, E. Schönbrunn, Jon E. Hawkinson, Debra J. Wolgemuth, Gunda I. Georg	2023	7
4	Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties European Journal of Medicinal Chemistry ·Yannick Fringeli, Кадырметов, Simon Bayle, Frank van der Wel, 신수진, Ataboyeva Khumorakhan Mukhammadjonovna, John Malsawma, Sylvia M. Frydman, Weian Yan, E. Schönbrunn, Derek R. Duckett, Andrii Monastyrskyi	2023	3
5	Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding Nature Communications ·Erik B. Faber, Frank van der Wel, Michael MacMillan‐Wang, Mario Albreto de la, Marita Daenekindt, Nan Wang, میترا بهرشی, В.Н. Егорова, 周亚辉, Annie Chandy Mathew, An‐Suei Yang, Hira Khalid, Jon E. Hawkinson, Nicholas M. Levinson, Vargheese M. Chennathukuzhi, Daniel A. Harki, E. Schönbrunn, Gunda I. Georg	2023	27
6	Bivalent BET Bromodomain Inhibitors Confer Increased Potency and Selectivity for BRDT via Protein Conformational Plasticity Journal of Medicinal Chemistry ·黃景裕, K Jedlicka, Kohji Okamoto, Hao Luo, Norbert Berndt, Jun Qi, Gunda I. Georg, E. Schönbrunn	2022	12
7	Discovery of Dual TAF1-ATR Inhibitors and Ligand-Induced Structural Changes of the TAF1 Tandem Bromodomain Journal of Medicinal Chemistry ·Kohji Okamoto, Leixiang Yang, Lihong Chen, Seteolu Bamidele, Junhao Lu, 신수진, Divoy Chhabra, Justin M. Lopchuk, Jiandong Chen, E. Schönbrunn	2022	17
8	Development of Dimethylisoxazole-Attached Imidazo[1,2-a]pyridines as Potent and Selective CBP/P300 Inhibitors Journal of Medicinal Chemistry ·姚文博韩冰范文州, 이임술, Doni I. P. Marselino, Seteolu Bamidele, Logan H. Sigua, Tingjian Wang, Deyao Li, Zied Gaieb, Gagan Dhawan, Ann-Christin Bergvall, Jon A. Erickson, Rommie E. Amaro, E. Schönbrunn, Jun Qi, Wei Zhang	2021	22
9	Tetrahydroindazole inhibitors of CDK2/cyclin complexes European Journal of Medicinal Chemistry ·Stefy Agnestasia, Kwon Ho Hong, Andreas Becker, Joseph S. Tash, E. Schönbrunn, Gunda I. Georg	2021	6
10	Inhibition of p53 DNA binding by a small molecule protects mice from radiation toxicity Oncogene ·Qingliang Li, Kohji Okamoto, Charles W. Stevenson, Mousumi Das, Lihong Chen, Chen Zhang, Harshani R. Lawrence, Gary W. Daughdrill, E. Schönbrunn, Haitao Ji, Jiandong Chen	2020	7
11	Identification and Screening of Selective WEE2 Inhibitors to Develop Non‐Hormonal Contraceptives that Specifically Target Meiosis ChemistrySelect ·Carol Hanna, Shan Yao, B. J. Gray, E. Schönbrunn, Gunda I. Georg, Jeffrey T. Jensen, Rebecca A. D. Cuellar	2019	7
12	Molecular Basis for the N-Terminal Bromodomain-and-Extra-Terminal-Family Selectivity of a Dual Kinase–Bromodomain Inhibitor Journal of Medicinal Chemistry ·Derek Ettensohn, Alice Reichembach Gelatti, Basma Mofed Shalaby, Neeraj K. Mishra, Huarui Cui, John C. Widen, Norbert Berndt, Jin-Yi Zhu, Tijana Tomasevic, Joseph J. Topczewski, E. Schönbrunn, Daniel A. Harki, William C. K. Pomerantz	2018	51
13	Potent Dual BET Bromodomain-Kinase Inhibitors as Value-Added Multitargeted Chemical Probes and Cancer Therapeutics Molecular Cancer Therapeutics ·S.W. Ember, Que T. Lambert, Norbert Berndt, Steven Gunawan, Muhammad Ayaz, Marilena Tauro, J. Zhu, Paula J. Cranfill, Patricia Greninger, Conor C. Lynch, Cyril H. Benes, Harshani R. Lawrence, Gary W. Reuther, Nicholas J. Lawrence, E. Schönbrunn	2017	41
14	Identification of a Novel Class of BRD4 Inhibitors by Computational Screening and Binding Simulations ACS Omega ·Bryce K. Allen, Saurabh Mehta, S.W. Ember, Jin-Yi Zhu, E. Schönbrunn, Nagi G. Ayad, Stephan C. Schürer	2017	28
15	Structure–Activity Studies of N‐Butyl‐1‐deoxynojirimycin (NB‐DNJ) Analogues: Discovery of Potent and Selective Aminocyclopentitol Inhibitors of GBA1 and GBA2 ChemMedChem ·B Kharshiing, Vijayalaxmi Gupta, 邓童, J. Zhu, Marta González Pajuelo, Agustín Valle, Joseph S. Tash, E. Schönbrunn, Jon E. Hawkinson, Gunda I. Georg	2017	13
16	RKI-1447 Is a Potent Inhibitor of the Rho-Associated ROCK Kinases with Anti-Invasive and Antitumor Activities in Breast Cancer Cancer Research ·Vittorio Caporali, Laser Confirence Exposition, Roberta Pireddu, Ying Sun, Nan Sun, Mathew P. Martin, E. Schönbrunn, Nicholas J. Lawrence, Saı̈d M. Sebti	2012	123
17	Ack1 Mediated AKT/PKB Tyrosine 176 Phosphorylation Regulates Its Activation PLoS ONE ·Kiran Mahajan, Domenico Coppola, Sridevi Challa, Bin Fang, Y. Ann Chen, Weiwei Zhu, Alexis S. Lopez, John M. Koomen, Robert W. Engelman, Sean Mills, Rebecca S. Muraoka-Cook, Jin Q. Cheng, E. Schönbrunn, Saı̈d M. Sebti, H. Shelton Earp, Nupam P. Mahajan	2010	129
18	Structural Basis of Glyphosate Tolerance Resulting from Mutations of Pro101 in Escherichia coli 5-Enolpyruvylshikimate-3-phosphate Synthase Journal of Biological Chemistry ·M.L. Healy-Fried, T. Funke, Melanie A. Priestman, Huijong Han, E. Schönbrunn	2007	72
19	The Crystal Structure of Dimeric Kinesin and Implications for Microtubule-Dependent Motility Cell ·Frank Kozielski, Stefan Sack, Alexander Marx, Manfred Thormählen, E. Schönbrunn, Valérie Biou, Andrew W. Thompson, Eckhard Mandelkow�	1997	330
20	Crystallization and Preliminary X-Ray Diffraction Analysis of UDP-N-acetylglucosamine Enolpyruvyltransferase ofEnterobacter cloacae Journal of Structural Biology ·Stefan Sack, Zbigniew Dauter, Christoph Wanke, Nikolaus Amrhein, Eckhard Mandelkow�, E. Schönbrunn	1996	5

About E. Schönbrunn

E. Schönbrunn is a scholar working on Hematology, Molecular Biology, Oncology, Cell Biology and Biotechnology, having authored 96 papers that have together received 5.4k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (25 papers), Multiple Myeloma Research and Treatments (18 papers), Cancer-related Molecular Pathways (18 papers), Ubiquitin and proteasome pathways (17 papers), Biochemical and Molecular Research (13 papers), Microtubule and mitosis dynamics (10 papers), Enzyme Structure and Function (10 papers) and Carbohydrate Chemistry and Synthesis (10 papers). The work is most often cited by research in Molecular Biology (3.8k citations), Pollution (581 citations), Cell Biology (802 citations), Hematology (420 citations) and Molecular Medicine (160 citations). E. Schönbrunn has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Susanne Eschenburg, Eckhard Mandelkow�, Alexander Marx, Huijong Han, Mathew P. Martin, Nikolaus Amrhein, T. Funke, Wolfgang Kabsch, S.H. Olesen and Gunda I. Georg. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Biological Chemistry, Biochemistry, ACS Chemical Biology and ChemMedChem.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact